Ousted Molina CEO: Insurers want return to pre-ACA exclusions for pre-existing conditions

Supporting the Affordable Care Act (ACA) is one possible explanation J. Mario Molina has for being unexpectedly fired as president and CEO of the managed care company his father founded, Molina Healthcare.

Molina was let go on May 2 along with brother, John, the company’s CFO. The board cited “disappointing financial performance” for the change in leadership, but Molina told POLITICO other factors may have been in play, from his outspoken criticism of ACA replacement efforts to a potential sale of the company to a larger insurer.

“I’m not aware that anyone is trying to acquire the company,” Molina said. “Certainly with John and I out of the way, it would make it easier.”

He didn’t back off from criticisms of current healthcare reform efforts in the interview, even suggesting other health plans are staying quiet because they want to see ACA regulations eliminated.

“They don’t like the health insurance tax and they would like to return to a time when they could exclude people with pre-existing conditions,” Molina said. “For them it would be a good thing to go back to the old way of doing things.”

Read the full article at the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup